Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Adjusted Shareholders' Net Income (Non-GAAP) by Quarter
Adjusted Shareholders' Net Income (Non-GAAP) ($M)
Elevance Health Adjusted Shareholders' Net Income (Non-GAAP): $1,520M in Q3 2026, up 12.7% from a year earlier.
Latest, Q3 2026
1,520
Period ended Sep 30, 2026
Change on a year earlier
+12.7%
1,349 in Q3 2025
History
40 quarters
Since Q4 2016
Sources
35
Documents cited below
Where the Q3 2026 figure comes from
“|| Adjusted shareholders' net income | $ | 1,520 | $ | 1,349 | 12.7 | % | $ | 5,916 | $ | 6,065 | (2.5) | %”
Source: 8-K ER (FY2026Q3, 2026-10-21) ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up adjusted Shareholders' Net Income (Non-GAAP)
Cite this data
StockData. (2026). Elevance Health Adjusted Shareholders' Net Income (Non-GAAP) ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/fin-adjusted-net-income
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.